Proposed Changes to MOPOP
Chapter 9: Descriptions
Consultation update
The Patent Branch received the following feedback during the November 16, 2009 to December 30, 2009 consultation period:
- Astra Zeneca
- Eli Lily Canada and Glaxo Smith Kline
- Fédération Internationale des Conseils en Propriété Industrielle
- Intellectual Property Institute of Canada (cover letter)
- Intellectual Property Institute of Canada
- Ogilvy Renault
- Rx & D
Important notice: Please note that access to this section is provided as a courtesy only. Therefore, comments are in the language in which they were submitted to CIPO.
Consultation period
Consultation period: November 16, 2009 to December 30, 2009
Consultation documents
Proposed MOPOP Chapter 9
Descriptions (PDF - 189 KB - 35 pages)
Contact information
Should you have any questions about this consultation, please send them by email to Chris Evans, by fax at 819-994-1989, or by regular mail to the following address:
- Canadian Intellectual Property Office
- Patent Branch
- 50 Victoria Street,
- Place du Portage II
- Gatineau, QC K1A 0C9
- Attention: Chris Evans
- Barney de Schneider
- Assistant Commissioner of Patents
- Canadian Intellectual Property Office